TUSC7 and exocrine pancreatic carcinoma: Notably, TUSC7 has been identified as significantly downregulated in various cancers, demonstrating tumor suppressive effects, including in osteosarcoma [18, 19], endometrial carcinoma [20], colorectal cancer [21, 22], and pancreatic carcinoma [23].